Permissive role of endothelin receptors in tumor metastasis.

Abstract

Metastasis remains the major driver of mortality in patients with cancer. The multistep metastatic process requires the concerted actions of several genes and involves tumor cell invasion, epithelial mesenchymal transition (EMT), shedding from primary tumor, intravasation, arrest, extravasation and colonization at a preferential site. Understanding this complex process would provide the basis for the development of molecularly targeted therapeutics aimed at the tumor cell or its interaction with the host microenvironment. The neuropeptide hormones endothelins (specially, ET-1) have been correlated with invasiveness and metastasis of several cancers and high ET-1 levels are associated with decreased disease-specific survival. The mechanism(s) by which ET-1 promotes metastasis are being gradually unraveled. Through preferential binding to cognate receptors (ET(A)R or ET(B)R), ET-1 triggers autocrine and paracrine signaling cascades in tumor, immune and stromal cells, at both primary and distant sites, supporting cancer progression and metastasis. In this review, we will summarize the role of the ET axis in metastasis of different cancers and potential targeting of ET receptors in the therapeutic setting.

• Authors: Neveen Said, Dan Theodorescu
• Journal: Life sciences (Life Sci) Vol. 91 Issue 13-14 Pg. 522-7 (Oct 15 2012) ISSN: 1879-0631 [Electronic] Netherlands
• PMID: 22846215 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
• Copyright: Copyright © 2012 Elsevier Inc. All rights reserved.

Chemical References

• Endothelin-1
• Receptor, Endothelin A
• Receptor, Endothelin B
• Receptors, Endothelin

Topics

• Drug Design
• Endothelin-1 (metabolism)
• Humans
• Molecular Targeted Therapy
• Neoplasm Invasiveness
• Neoplasm Metastasis
• Neoplasms (drug therapy, pathology)
• Receptor, Endothelin A (metabolism)
• Receptor, Endothelin B (metabolism)
• Receptors, Endothelin (metabolism)